The Office of the Governor has appointed Kathy He, founder and president of the biotech company VIVREGEN, as a member of the Illinois Mathematics and Science Academy® (IMSA) Board of Trustees.
He, who is also the parent of an IMSA senior, is founder and president of VIVREGEN, a biotech company focused on the development and commercialization of regenerative therapies to improve animal and human health.
IMSA President Dr. Glenn W. “Max” McGee said He’s global experience as a business entrepreneur, business executive in the pharmaceutical and medical device field and experience as an IMSA parent will bring unique insight and leadership to the board.
“He’s leadership in marketing, product development, global business negotiations and entrepreneurship in the STEM fields at some of the world’s leading companies will be invaluable as we work to position IMSA as the world’s leading teaching and learning laboratory for imagination and inquiry for the next 25 years and beyond,” Dr. McGee said.
He has an MBA in Marketing, Strategy and Technology from
Prior to founding her own biotech company, He worked in worldwide marketing, new product planning and corporate strategy and business development at Abbott Diagnostics, Merck & Co., Takeda Pharmaceuticals and Prosorp Biotech Inc.
The internationally recognized Illinois Mathematics and Science Academy® (IMSA) develops creative, ethical leaders in science, technology, engineering and mathematics. As a teaching and learning laboratory created by the State of Illinois, IMSA enrolls academically talented Illinois students (grades 10-12) in its advanced, residential college preparatory program, and it serves thousands of educators and students in Illinois and beyond through innovative instructional programs that foster imagination and inquiry. IMSA also advances education through research, groundbreaking ventures and strategic partnerships. (www.imsa.edu)
For information contact email@example.com.